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ABSTRACT 
 
Use of indocyanine green (ICG), an FDA-approved dye, in a pump-probe scheme for optical coherence tomography 
(OCT) is reported. Aqueous solutions of ICG are not stable, i.e., the dye degrades over time especially in the presence 
of light. Addition of protein such as bovine serum albumin (BSA) stabilizes the ICG; however, when exposed to high 
intensity illumination, the dye still degrades. Moreover, the photodegradation is permanent and occurs swiftly if the 
illumination band corresponds to the ICG absorption peak. The permanence of the photobleached state illustrates that 
ICG photobleaching phenomenon has great potential to achieve contrast in OCT. ICG solutions with 50 µM 
concentration were prepared in water, 1% BSA, and 0.8% agarose to study the dynamics of the dye for different 
illumination intensity levels. In addition, different molar concentrations of ICG in water were studied for fixed 
illumination intensity. In each case, probability of photobleaching, defined as the ratio of the total photobleached ICG 
molecules to the total photons absorbed by the ground-state molecules, is evaluated to characterize the photobleaching 
phenomenon in ICG. We also demonstrate ICG-based pump-probe MCOCT imaging by mapping the distribution of 
ICG in a stage 54 Xenopus laevis. 
 
Keywords: Optical coherence tomography, Indocyanine green, Medical and biological imaging, Pump-probe 
 
1. INTRODUCTION 
 
Optical coherence tomography1 (OCT) is a vital non-invasive biomedical tool for high resolution imaging of biological 
samples to a depth of few millimeters. Since its inception, OCT has matured into a useful diagnostic tool for ophthalmic 
applications.2, 3 OCT’s applications for imaging other areas of the human body include endoscopic imaging of 
gastrointestinal (GI) tract 4 and bladder 5 for tumor detection, monitoring and risk assessment of vulnerable lipid plaques 
in the vascular system,6 monitoring intracoronary stenting,7 and tracking structural weakness associated with tooth 
decay.8 While a basic OCT imaging method is able to render depth resolved structural images of the target, more 
sophisticated OCT imaging strategies can provide additional functional information such as flow (through Doppler 
OCT),9 tissue structural arrangement (through birefringence OCT),10 and depth resolved spectral signatures (through 
spectral OCT).11, 12  Recently, a new and exciting type of functional OCT method, known as molecular contrast optical 
coherence tomography (MCOCT),13-16 has been introduced that combines the major advantages of fluorescence 
microscopy (chemical contrast detection and imaging capability) and OCT (higher spatial resolution and depth 
penetration). MCOCT schemes reported so far can be categorized into three major groups; namely, absorption, 
coherent-emission, and scattering based MCOCT. This paper deals with a pump-probe MCOCT scheme that falls within 
the first category, i.e., absorption-based MCOCT.  
 
In pump-probe MCOCT, a baseline OCT scan of the sample containing a contrast agent is first acquired, followed by 
photo-excitation of the contrast agent. The photo-illumination alters the absorption extinction coefficient of the contrast 
agent. A second OCT scan is then acquired. The two OCT scans are slightly different as the absorption spectrum of the 
contrast agent has changed. The two OCT scans are thus processed to determine the distribution of the contrast agent 
within the sample. The first reported pump-probe MCOCT scheme used methylene blue (MB) as the contrast agent.13 
Notice that the triplet state in MB has a life time of only ~2 µs, which requires very strong illumination intensity, e.g., > 
10 MW/cm2, of the pump source to achieve contrast. A contrast agent with higher absorption cross section and longer 
life time is therefore highly desirable. Recently, indocyanine green (ICG), which is frequently used in medical 
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diagnostics17 and photodynamic therapy,18 was used as a contrast agent in an MCOCT implementation in which contrast 
agent’s distribution inside the sample was determined from agent’s spectral differential absorption.16 Later, a pump-
scheme for MCOCT was proposed using ICG as a contrast agent.19 This paper extends on the same idea and provides 
better understanding of ICG dynamics in a pump-probe scheme. We also demonstrate the MCOCT technique in an 
animal model. 
 
 
Figure 1: Schematic of electronic state diagram of ICG. σG is the ground state absorption cross section whereas φT, φP, and φB are 
quantum yields of triplet (T), P-isomer (P), and bleached (B) states. 
 
In addition to the ground and first excited states, ICG has three more states of interest, namely the triplet (T), P-isomer 
(P), and bleached (B) states, in which the molecules can reside (see Fig.1).  The quantum yields φT, φP, and φB of the 
three states are very small (~10-5 – 10-6),20 so most of the excited state molecules relax directly back to the ground state 
(fluorescence signal). The life times of triplet and P-isomer states are small, i.e., τT ~700 µs and τP ~10 ms, 
respectively.20 Low quantum yield and small life times indicate that triplet and P-isomer states cannot accumulate 
enough ICG molecules to deliver noticeable contrast. However, the photobleached state, with similarly low quantum 
yield, is permanent. This implies that, given enough time, all the molecules in an illuminated sample of ICG solution 
can be sent to the bleached state.  
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Figure 2: Absorption cross section spectra of unbleached as well as bleached samples of ICG in 1% BSA and water. ICG 
concentration is 50 µM in all the cases. 
 
For the sake of substantiation, 1 cm path length glass cuvettes (from Starna Cells, Inc.) were filled with 50 µM ICG 
solutions in 1% bovine serum albumin (BSA) and water, and exposed to 790 nm illumination (incident optical power ~ 
1.2 Watts) for several hours. Figure 2 shows absorption cross section spectra of both unbleached and bleached samples 
of 50 µM ICG solution in 1% BSA and water. The absorption cross section spectra of the bleached samples of ICG in 
1% BSA and water showed no signs of recovering, confirming that the photobleached state is permanent. The 
permanence of photobleaching illustrates the usefulness of this transition in a pump-probe scheme for OCT – a focus of 
this study.  
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2. DEGRADATION DYNAMICS OF INDOCYANINE GREEN 
 
Figure 3 shows a setup to study the degradation dynamics of ICG. A fraction of the collimated beam from the light 
source (Ti:Sapphire laser) is split off using a beam splitter (BS) to form the reference beam. The major portion of the 
light, i.e., the signal beam passes through a small self-assembled 1.52 mm path length circular cuvette, 1.98 mm in 
diameter. The diameter of the collimated laser beam is approximately the size of the circular cuvette diameter. A 
balanced photodetector (New Focus, Inc.) is used to measure the transmission through the ICG samples versus time.  
 
   
 
Figure 3: Experimental setup to study ICG photodegradation dynamics. M: Mirror; BS: Beamsplitter; A: Attenuator; R: Reference 
beam; S: Sample beam. 
 
First, ICG (product # SDB8662, acquired from H. W. Sands Corp.) was used to prepare 50 µM solutions in deionized 
(DI) water, 1% BSA, and 0.8% agarose to study ICG sample transmission versus time for different illumination 
intensities. Note that before each transmission measurement, the system was balanced by using the corresponding 
solvent (water, 0.8% agarose, or 1% BSA) in an identical cuvette and adjusting the free-space attenuators A1 and A2 
accordingly. Figure 4 shows the transmission curves of 50 µM ICG in water, 1% BSA, and 0.8% agarose for different 
illumination intensities. 
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Figure 4: Transmission curves for 50 µM ICG versus time in (a) DI water, (b) 1% BSA, and (c) 0.8% agarose for different 
illumination intensities. Note that fresh samples of ICG were used for different illumination intensities of the laser. 
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The quantum yield of the bleached state may also be thought of as the probability of photobleaching, φB, defined as the 
ratio of total number of photobleached molecules to the total number of photons absorbed by ground state molecules. 
Considering only ground, excited, and photobleached states (see Fig. 1), the bleached state population density NB(t) can 
be written in terms of transmission T(t) as: 
( ) ( )
( )⎥⎦
⎤⎢⎣
⎡
−= min
ln1
T
tT
L
tN
BG
B σσ ,     (1) 
where L is the sample path length and { }LNT G 0min exp σ−=  is the minimum transmission at t = 0. For a 50 µM ICG 
concentration, N0, the number of ICG molecules per unit volume, is 3.011×1016 cm-3. Because the illumination intensity 
decays through the sample, ( )tNB represents spatial average of the bleached state population density varying with 
exposure time. Therefore, the probability of photobleaching, φB, can be mathematically written as:  
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,    (2) 
where V is the volume of the ICG sample, h is Planck’s constant, ν is the optical frequency of illumination, P0 is the 
incident optical power, and ( ) ( )tTPtP ×= 0 is the transmitted power. The term ( )( )0/1 NtNB−  assures that only the 
photons absorbed by the ground state ICG molecules are considered. It can be seen from Eq. (2) that the probability of 
photobleaching, φB(t), is a function of time. Moreover, φB(t) determined in this fashion yields a probability which is 
cumulative in nature such that at a given time t′, φB,cum(t′) gives an average probability of photobleaching for time 
interval [0, t′].  
 
The transmission data shown in Fig. 4 were processed to determine probability of photobleaching using Eqs. (1) and (2). 
It was found that the probability of photobleaching in ICG does change with exposure time. However, it does not vary 
significantly with the illumination intensity. For each sample of ICG (in water, BSA, and agarose), the probability 
curves for different illumination intensity were averaged; Figs 5 (a) shows average φB,cum(t) curve for 50 µM ICG in 
water. This empirical study shows that probability of photobleaching, φB,cum(t), decreases with exposure time.  
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Figure 5: (a) Average φB,cum(t) curves for 50 µM ICG in DI water. (b) Initial probability of photobleaching φB,cum,init [determined 
using Eq. (2)] versus ICG concentration. The illumination intensity is 33.55 W/cm2. 
 
We also studied the photobleaching phenomenon in various other concentrations of ICG in DI water. To keep the initial 
transmissions alike for different concentrations of ICG, glass cuvettes with different path lengths were assembled in our 
laboratory. ICG concentrations ranging from 12 µM to 137 µM were used in the study. The input illumination intensity 
on each sample was ~33.55 W/cm2. For each concentration, several sets of measurements were acquired to assure 
accuracy. The transmission curves were processed to determine probability of photobleaching versus time, using the 
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cumulative approach defined by Eq. (2). The initial probability of photobleaching φB,cum,init versus ICG concentration is 
shown in Fig. 5(b), where a decrease in φB,cum,init with increasing dye concentration can be clearly seen. Note that curve 
fitting the data in Fig. 5(b) with a decaying exponential can be used to estimate initial probability of photobleaching for 
higher concentrations of ICG. This study shows that samples of ICG prepared in higher concentrations are more stable 
than the one prepared in lower concentrations. 
 
 
3. PUMP-PROBE MOLECULAR CONTRAST OPTICAL COHERENCE TOMOGRAPHY SETUP 
 
Figure 6(a) shows a fiber-optic spectral domain MCOCT setup that uses a high power broadband laser such as a 
Ti:Sapphire. A programmable fiber-optic attenuator (PFOA) realized using a galvanometer-based mirror scanner 
controls the amount of light reaching the sample during ICG photobleaching as well as OCT signal acquisition. A 
personal computer both controls the PFOA and acquires data from the spectrometer. From operational point of view, the 
PFOA is first set to deliver low optical power, usually less than 100 µW, so that ICG is as little photobleached as 
possible during the first OCT scan. After the first OCT scan is acquired at time t1, the PFOA is set to deliver high 
power, usually 1000×, for set duration ∆t to photobleach the ICG. The optical power transmitted by the PFOA is then 
reduced to the same level as for the first OCT scan to acquire the second OCT scan at time t2. The timing diagram of the 
pump-probe scheme is shown in Figure 6(b). 
 
 
  (a)                             (b) 
Figure 6: (a) Proof- of- concept pump-probe MCOCT setup. PC: Polarization controller, SMF: Single mode fiber; PFOA: 
Programmable fiber-optic attenuator, FC: Fiber collimator. (b) Timing diagram for pump-probe scheme. 
  
At the interferometer, the light collected from the reference and sample arms is spectrally dispersed using a diffraction 
grating and detected using N different detectors. For the spectral domain MCOCT setup shown in Fig. 6(a), the 
spectrally resolved interferometric OCT signal can be mathematically expressed as: 
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where k is the optical wavenumber, S(k) is the source spectral profile, η(k) is optical power split factor of the 2×2 
coupler (½ in an ideal case), RR is the reflectivity of the reference mirror, ),( zRs λ  is the sample reflectivity at depth z, 
and )( rzz −  is the path length difference between the reference arm mirror and the plane of interest inside the sample. 
),( za λµ and ),( zs λµ are the absorption and scattering coefficients, respectively, of the sample. In a pump-probe 
scheme such as the one discussed above using ICG as the contrast agent, the photo-illumination permanently alters the 
absorption coefficient of the dye. In this context, the absorption coefficient can be mathematically written as: 
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 ),(),(),(),(
ICG,ICG_ground, intrinsic,
zzzz aaaa λµλµλµλµ ∆++= ,  (4) 
where ),(
 intrinsic,
za λµ is the localized intrinsic absorption coefficient of the sample, ),( ICG_ground, za λµ is the localized 
absorption coefficient component for ICG in the ground state, and ),(
ICG,
za λµ∆ is the change in the absorption 
coefficient between the two OCT scans. The two quantities, ),(
 ICG_ground,
za λµ and ),(ICG, za λµ∆ , can be expressed as: 
)()(),( 0 ICG_ground, zNz Ga λσλµ = ,     (5) [ ] )()()()()()(),( 0ICG, zNzNzNz GBBGGa λσλσλσλµ −+=∆ .  (6) 
where )(λσ G and )(λσ B are the ground and bleached state absorption cross section spectra, respectively. )(0 zN is 
the initial ground state population density of ICG, whereas )(zNG and )(zN B are the ground and bleached state 
population densities when the second OCT scan is acquired. Since the lifetime of ICG molecules in the excited state is 
extremely small (~ in ps), we can safely assume that )()()(0 zNzNzN BG += . Therefore, Eq. (6) can be simplified as: 
[ ] )()()(),(
ICG,
zNz BGBa λσλσλµ −=∆ .    (7) 
If Pinterference_ground(λ,z) and Pinterference_bleached(λ,z) are the OCT signals acquired before and after the photobleaching of 
ICG, the change in absorption coefficient is related to the two OCT scans by: 
⎥⎥⎦
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4. EXPERIMENT 
 
A spectral domain MCOCT system similar to that shown in Fig. 6(a) was realized for demonstration. Light from a 
modelocked Ti:Sapphire laser (~12 nm FWHM) is coupled into a long 5/125 µm SMF for spectrum broadening. 
Broadband probe light (~60 nm FWHM centered at 800 nm) reaches the 2×2 single mode fiber-optic coupler via a 
galvo-based PFOA. Light from the coupler is collimated by lens L1 ( f1 = 11mm) and focused onto the sample by a 10× 
microscope objective lens ( f2 = 16.5 mm). The calculated 1/e2 focal spot size on the sample is 8.24 µm, which 
corresponds to a depth of focus of 135 µm. Light collected from the two arms of the interferometer is detected by a 
spectrometer designed and built in our laboratory, which features 0.07 nm spectral resolution. The spectral oscillation 
data acquired by the spectrometer are first rescaled and resampled evenly in k-space, before it is Fourier transformed to 
retrieve the sample depth profile (or A-scan). Our laboratory MCOCT system features a base SNR of ~90 dB at 0.8 
millisecond integration time. 
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Figure 7: (a) Side view of a self-assembled 0.84 mm path length glass cuvette. (b) A-scans of the glass cuvette filled with a mixture 
of 200 µM ICG and 0.25% volume concentration 0.1-µm latex microspheres before and after the photobleaching. (c) Ratio of the two 
A-scans is shown in Fig. 7(c). 
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In a proof-of-concept demonstration, a self assembled 0.84 mm path length glass cuvette, filled with a mixture of 200 
µM ICG and 0.25% (v/v) 0.1-µm latex microspheres, was used as a sample [see Fig. 7(a)]. The galvo-based PFOA was 
programmed to deliver 68 µW and 10 mW optical power levels on the sample for OCT signal acquisition and ICG 
photobleaching, respectively. The ICG was photobleached for duration ∆t = 2.5 seconds between the two OCT scans. 
Figure 7(b) shows averaged A-scans of the glass cuvette before (blue) and after (red) the photobleaching. The first two 
interfaces show no contrast as anticipated. The last two interfaces of the glass cuvette yield a measured contrast of ~ 5 
dB. Notice that the contrast increases with ICG sample depth as it is cumulative in nature [see Eq. (8)]. A ratio of the 
two averaged A-scans is shown in Fig. 7(c) to support the argument.  
 
   
 
 
 
  
 
Figure 8: MCOCT imaging of a stage 54 Xenopus laevis. (a) Ventral view of Xenopus laevis filled with a mixture of 400 µM ICG 
and 0.25% - 0.1µm latex microspheres; the red line indicates the region where OCT scans were acquired. (b) and (c) show B-scans of 
the illuminated region before and after ICG photobleaching, respectively.  
 
To demonstrate the ICG detection capability in an animal model, a mixture of 400 µM ICG, ~0.25% volume 
concentration 0.1 µm latex microspheres, and 0.6% volume concentration of agarose was filled in gill arch cavities of 
euthanized stage 54 Xenopus laevis. First, the PFOA was set to illuminate the sample with ~60 µW and a whole B-scan 
(400 A-scans; lateral resolution ~7.5 µm) was acquired by moving the sample using a linear stage [see Fig. 8(b)]. 
During the second B-scan, the PFOA was set to illuminate the sample with ~10mW power at each A-scan position for 
12 sec duration.  The optical power was then readjusted to ~60 µW to acquire the corresponding A-scan, and so forth. 
Figure 8(c) shows the second B-scan where increased backscatter from the microspheres (indicating the localization of 
ICG) in gill arch cavities can be clearly seen. This increased backscatter, attributable to change in the absorption 
coefficient of ICG from within the gill arch cavities of the tadpole, demonstrates the functionality of ICG as contrast 
agent in the proposed pump-probe MCOCT scheme. 
 
 
5. CONCLUSION 
 
In conclusion, we have conducted a study of ICG photobleaching in water, BSA, and agarose. The study indicates that 
the photobleached state is permanent, which makes this transition useful in a pump-probe scheme for OCT. Exposure of 
ICG solutions in DI water, BSA, and agarose with different illumination intensity levels shows that the probability of 
photobleaching decreases with exposure time in all the cases. The study of various concentrations (ranging from 12 µM 
to 137 µM) of ICG in DI water for a fixed illumination intensity illustrates that the initial probability of photobleaching 
also decreases with increasing concentration. This information can be used to estimate the initial probability of 
photobleaching for higher concentrations, which helps understand the dynamics of ICG when used as a contrast agent in 
a pump-probe MCOCT scheme. Using our laboratory spectral domain MCOCT setup, which utilizes a Ti:Sapphire laser 
coupled to a galvo-based PFOA, we have successfully demonstrated, for the first time, ICG-based pump-probe MCOCT 
by mapping the dye distribution within gill arch cavities of a stage 54 Xenopus laevis. We strongly believe that the 
ability of ICG to provide high contrast in pump-probe MCOCT, combined with its high affinity to bind with proteins, 
and FDA approval for use in humans, can help realize an exciting functional imaging modality providing both high 
resolution, depth-resolved, structural information of tissue, as well as the ability to differentiate between certain tissue 
pathologies. In future, we plan to investigate other molecular contrast agents, specifically with higher probability of 
bleaching as well as larger absorption cross section, for use in our pump-probe MCOCT scheme. 
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